HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gregory Moeck Selected Research

oritavancin

1/2017Assessment of the potential for oritavancin MIC changes among Staphylococcus aureus nasal carriage isolates following systemic oritavancin treatment in a phase 2 study in patients with acute bacterial skin and skin-structure infections.
12/2015In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
12/2012Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
2/2012Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus.
12/2010Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing.
12/2009Time-kill kinetics of oritavancin and comparator agents against Streptococcus pyogenes.
6/2009Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
10/2008Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gregory Moeck Research Topics

Disease

10Infections
01/2017 - 10/2008
4Osteomyelitis
02/2010 - 10/2008
1Sepsis (Septicemia)
01/2021
1Clostridium Infections
12/2012
1Endocarditis
02/2012

Drug/Important Bio-Agent (IBA)

8oritavancinIBA
01/2017 - 10/2008
4VancomycinFDA LinkGeneric
12/2015 - 06/2009
4ProdrugsIBA
02/2010 - 10/2008
3DaptomycinFDA Link
12/2015 - 06/2009
3Linezolid (Zyvox)FDA Link
12/2015 - 06/2009
3LipoglycopeptidesIBA
12/2015 - 10/2008
3Anti-Bacterial Agents (Antibiotics)IBA
02/2010 - 10/2008
2TeicoplaninIBA
12/2009 - 06/2009
2FluoroquinolonesIBA
11/2008 - 10/2008
1carbapenemaseIBA
01/2021
1Ceftibuten (Cedax)FDA Link
01/2021
1GlycopeptidesIBA
02/2010
1Penicillins (Penicillin)FDA Link
12/2009
1Erythromycin (Erycette)FDA LinkGeneric
12/2009
1KRM 1648IBA
12/2008
1Pharmaceutical PreparationsIBA
11/2008
1Diphosphonates (Bisphosphonates)IBA
11/2008
1EstersIBA
10/2008